K
24.58
-0.34 (-1.36%)
Previous Close | 24.92 |
Open | 24.92 |
Volume | 246,254 |
Avg. Volume (3M) | 492,184 |
Market Cap | 1,217,540,864 |
Price / Sales | 26.57 |
52 Weeks Range |
Profit Margin | -183.65% |
Operating Margin (TTM) | -136.64% |
Diluted EPS (TTM) | -1.89 |
Quarterly Revenue Growth (YOY) | 189.90% |
Total Debt/Equity (MRQ) | 104.86% |
Current Ratio (MRQ) | 2.81 |
Operating Cash Flow (TTM) | -66.27 M |
AIStockmoo Score
0.4
Analyst Consensus | 0.5 |
Insider Activity | NA |
Price Volatility | 1.0 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 0.0 |
Average | 0.38 |
% Held by Insiders | 6.32% |
% Held by Institutions | 50.37% |
52 Weeks Range | ||
Price Target Range | ||
High | 29.00 (Wolfe Research, 17.98%) | Buy |
Median | 28.00 (13.91%) | |
Low | 24.00 (Goldman Sachs, -2.36%) | Hold |
Average | 27.20 (10.66%) | |
Total | 4 Buy, 1 Hold | |
Avg. Price @ Call | 24.92 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Goldman Sachs | 31 Mar 2025 | 24.00 (-2.36%) | Hold | 24.92 |
Piper Sandler | 31 Mar 2025 | 27.00 (9.85%) | Buy | 24.92 |
Stifel | 31 Mar 2025 | 28.00 (13.91%) | Buy | 24.92 |
Wells Fargo | 31 Mar 2025 | 28.00 (13.91%) | Buy | 24.92 |
Wolfe Research | 31 Mar 2025 | 29.00 (17.98%) | Buy | 24.92 |
No data within this time range.
Date | Type | Details |
---|---|---|
14 Mar 2025 | Announcement | Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering |
07 Mar 2025 | Announcement | Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |